ESCITALOPRAM CAPSULES 15MG
Live / Allowed — First extension granted (statement of use) (as of 09 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99315852
- Mark type
- Design + words
- Filed
- 01 Aug 2025
- Published for opposition
- 20 Jan 2026
- Attorney of record
- GREGG A. PARADISE
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders
Owner
- Almatica Pharma LLC, Morristown, NJ, US
- Almatica Pharma LLC, Morristown, NJ, US
Prosecution history
- 10 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2026 — SOU EXTENSION 1 GRANTED
- 09 Sept 2026 — SOU EXTENSION 1 FILED
- 09 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jan 2026 — PUBLISHED FOR OPPOSITION
- 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Dec 2025 — EXAMINER'S AMENDMENT ENTERED
- 21 Dec 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 21 Dec 2025 — EXAMINERS AMENDMENT E-MAILED
- 21 Dec 2025 — EXAMINERS AMENDMENT -WRITTEN
- 17 Dec 2025 — ASSIGNED TO EXAMINER
- 10 Dec 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED